Karuna Therapeutics, Inc

(NASDAQ:KRTX)

Latest On Karuna Therapeutics, Inc (KRTX):

Date/Time Type Description Signal Details
2023-05-06 04:28 ESTNewsKaruna Therapeutics, Inc. (KRTX) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 13:47 ESTNewsKaruna Therapeutics GAAP EPS of -$2.80 misses by $0.01, revenue of $0.65MN/A
2023-05-04 01:22 ESTNewsKaruna Therapeutics Q1 2023 Earnings PreviewN/A
2023-03-23 21:07 ESTNewsRoyalty Pharma, PureTech in pact for royalties in Karuna’s lead assetN/A
2023-03-22 13:22 ESTNewsKaruna Therapeutics prices ~$400M stock offeringN/A
2023-03-22 13:22 ESTNewsKaruna's KarXT: Limited Distinction In Schizophrenia, Yet Warrants Hopeful MonitoringN/A
2023-03-21 22:01 ESTNewsKaruna Therapeutics extends decline on $400M stock offeringN/A
2023-03-21 22:00 ESTNewsKaruna extends selloff while Wall Street backs schizophrenia candidateN/A
2023-03-20 15:34 ESTNewsKaruna/ Zai Lab succeed in late-stage trial for schizophrenia candidateN/A
2023-03-08 11:45 ESTNewsKaruna initiated Neutral at Cantor citing lead candidate KarXTN/A
2023-02-24 19:25 ESTNewsKaruna Therapeutics: Best Nearby Biotech Cap-Gain Wealth Builder StockN/A
2023-02-23 16:35 ESTNewsKaruna Therapeutics GAAP EPS of -$2.22 beats by $0.06, revenue of $5.28MN/A
2023-02-02 20:44 ESTNewsKaruna to pay $15M upfront in licensing deal for potential mental disorder drugsN/A
2023-01-31 17:21 ESTNewsKaruna appoints former BioXcel exec as chief commercial officerN/A
2022-12-08 09:52 ESTNewsKaruna: Acquisition Prospects Thin With CEO ChangeN/A
2022-12-06 21:36 ESTNewsKaruna Therapeutics drops 12% after CEO changeN/A
2022-11-03 11:30 ESTNewsKaruna Therapeutics GAAP EPS of -$2.38 misses by $0.27N/A
2022-10-05 23:23 ESTNewsKaruna Therapeutics falls as CFO sells over $3M sharesN/A
2022-09-10 00:15 ESTNewsKaruna Therapeutics: This Ship Has SailedN/A
2022-09-10 00:15 ESTNewsKaruna's High Share Price Following Schizophrenia Data Gives Me VertigoN/A
2022-08-15 01:10 ESTNewsKaruna Therapeutics, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-12 21:26 ESTNewsKaruna Therapeutics closes ~$863M underwritten public offeringN/A
2022-08-10 19:26 ESTNewsKaruna Therapeutics prices upsized $750M stock offeringN/A
2022-08-09 04:32 ESTNewsKaruna Therapeutics GAAP EPS of -$2.17 misses by $0.10, revenue of $5.28MN/A
2022-08-09 04:32 ESTNewsKaruna Therapeutics jumps 52% as schizophrenia trial meets key goalN/A
2022-08-09 04:31 ESTNewsKaruna Therapeutics announces $600M stock offeringN/A
2022-08-09 04:31 ESTNewsHot Stocks: BBBY leads meme stocks higher; KRTX surges 72%; TSN drops on earnings; CYBE jumps to 52-week highN/A
2022-07-02 01:09 ESTNewsKaruna Therapeutics trims losses after over $14M insider purchaseN/A
2022-06-26 15:59 ESTNewsKaruna Therapeutics: Front-Running KarXT Phase 3N/A
2022-05-06 04:38 ESTNewsKaruna Therapeutics GAAP EPS of -$1.95 beats by $0.19N/A
2022-02-24 14:46 ESTNewsKaruna Therapeutics GAAP EPS of -$0.94, revenue of $36.96MN/A
2022-02-24 14:46 ESTNewsKaruna pulls guidance for late-stage trial in Ukraine after Russia's invasionN/A
2022-02-24 14:46 ESTNewsKaruna Therapeutics (KRTX) Presents At Annual SVB Leerink Global Health ConferenceN/A
2022-01-14 10:06 ESTNewsKaruna Therapeutics: Starting A Position With 50% Short-Term Upside PotentialN/A
2022-01-13 00:47 ESTNewsKaruna Therapeutics (KRTX) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2021-12-19 14:24 ESTNewsAlnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022N/A
2021-11-09 11:56 ESTNewsKaruna Therapeutics, Zai Lab team up for experimental psychiatric therapy in ChinaN/A
2021-11-04 11:49 ESTNewsKaruna Therapeutics EPS misses by $0.27N/A
2021-08-06 05:57 ESTNewsKaruna Therapeutics EPS beats by $0.12N/A
2021-07-21 14:01 ESTNewsKaruna Therapeutics reports KarXT results from Phase 1b study in healthy elderly volunteersN/A
2021-07-21 13:45 ESTNewsKaruna Therapeutics: Clear Path To NDAN/A
2021-05-06 14:47 ESTNewsKaruna Therapeutics EPS in-lineN/A
2021-03-18 21:40 ESTNewsKaruna Therapeutics (KRTX) Presents At 10th Annual SVB Leerink Global Healthcare ConferenceN/A
2021-03-13 03:09 ESTNewsMerck and Pfizer among top picks to lead 2021 biopharma M&A activity: Goldman SachsN/A
2021-03-05 11:52 ESTAnalyst RatingThe Analyst Target Price has increased from $159.83 to $160.08.Buy
2021-03-03 11:55 ESTAnalyst RatingThe Analyst Target Price has increased from $154.83 to $159.83.Buy
2021-03-02 15:07 ESTNewsKaruna Therapeutics secures $250M capital via equity raiseN/A
2021-03-02 11:56 ESTAnalyst RatingThe Analyst Target Price has increased from $153.33 to $154.83.Buy
2021-03-01 19:58 ESTNewsKaruna Therapeutics to raise capital in proposed public offeringN/A
2021-03-01 11:51 ESTAnalyst RatingThe Analyst Target Price has increased from $150.5 to $153.33.Buy

About Karuna Therapeutics, Inc (KRTX):

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that has completed Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia; and in Phase Ib clinical trial for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

KRTX Quotes by TradingView

See Advanced Chart

General

  • Name Karuna Therapeutics, Inc
  • Symbol KRTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 63
  • Fiscal Year EndDecember
  • IPO Date2019-06-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.karunatx.com
View More

Valuation

  • Trailing PE 0.16
  • Price/Book (Most Recent Quarter) 9.52
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$5.52
  • Next Year EPS Estimate -$5.77
  • Next Quarter EPS Estimate -$1.01
  • Return on Assets -12%
  • Return on Equity -19%
  • Earnings Per Share -$254.14
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.19 billion
  • EBITDA -37236000
  • Analyst Target Price $160.08
  • Book Value Per Share $6.94
View More

Share Statistics

  • Shares Outstanding 27.02 million
  • Shares Float 19.89 million
  • % Held by Insiders 1453%
  • % Held by Institutions 87.42%
  • Shares Short 1.53 million
  • Shares Short Prior Month 1.46 million
  • Short Ratio 6.72
  • Short % of Float 12%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $146.97
  • 52 Week Low $58.13
  • 50 Day Moving Average 117.32
  • 200 Day Moving Average 97.74
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Karuna Therapeutics, Inc (KRTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Karuna Therapeutics, Inc (KRTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.89-$0.978.32%
2020-09-302020-11-05$N/A-$0.71-$0.8516.13%
2020-06-302020-08-05$N/A-$0.65-$0.44-46.83%
2020-03-312020-05-07$N/A-$0.33-$0.3914.29%
2019-12-312020-03-24$N/A-$0.32-$0.4833.11%
2019-09-302019-11-07$N/A-$0.39-$0.4616.11%
2019-06-302019-08-08$N/A-$1.15-$0.88-30.22%

Karuna Therapeutics, Inc (KRTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Karuna Therapeutics, Inc (KRTX) Chart:

KRTX chart by TradingView

Karuna Therapeutics, Inc (KRTX) News:

Below you will find a list of latest news for Karuna Therapeutics, Inc (KRTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Karuna Therapeutics, Inc (KRTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest KRTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$96.49
Jun 13, 2022 7:59 PM EST14$96.4
Jun 13, 2022 7:59 PM EST100$96.5
Jun 13, 2022 7:59 PM EST1$96.4
Jun 13, 2022 7:59 PM EST1$96.47

Karuna Therapeutics, Inc (KRTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-02S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1771917/000119312520186859/0001193125-20-186859-index.htm
2019-04-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1771917/000000000019007652/0000000000-19-007652-index.htm
2019-05-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1771917/000000000019008783/0000000000-19-008783-index.htm
2019-06-13UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1771917/000000000019009851/0000000000-19-009851-index.htm
2019-11-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1771917/000000000019015181/0000000000-19-015181-index.htm
2019-12-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1771917/000031506619001814/0000315066-19-001814-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018414/0000899243-19-018414-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018415/0000899243-19-018415-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018416/0000899243-19-018416-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018420/0000899243-19-018420-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018423/0000899243-19-018423-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018426/0000899243-19-018426-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018428/0000899243-19-018428-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018429/0000899243-19-018429-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018430/0000899243-19-018430-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018434/0000899243-19-018434-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018435/0000899243-19-018435-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018436/0000899243-19-018436-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018438/0000899243-19-018438-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018720/0000899243-19-018720-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018724/0000899243-19-018724-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018725/0000899243-19-018725-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018727/0000899243-19-018727-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018739/0000899243-19-018739-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018745/0000899243-19-018745-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018747/0000899243-19-018747-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018905/0000899243-19-018905-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018907/0000899243-19-018907-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018910/0000899243-19-018910-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018912/0000899243-19-018912-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018913/0000899243-19-018913-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924319018918/0000899243-19-018918-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320000296/0000899243-20-000296-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320000737/0000899243-20-000737-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320000978/0000899243-20-000978-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320001979/0000899243-20-001979-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320005042/0000899243-20-005042-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320005043/0000899243-20-005043-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320005045/0000899243-20-005045-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320005046/0000899243-20-005046-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320007992/0000899243-20-007992-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320008109/0000899243-20-008109-index.htm
2020-04-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320011438/0000899243-20-011438-index.htm
2020-05-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320014094/0000899243-20-014094-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320018956/0000899243-20-018956-index.htm
2020-08-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320022410/0000899243-20-022410-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320022412/0000899243-20-022412-index.htm
2020-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320023459/0000899243-20-023459-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320023521/0000899243-20-023521-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000089924320024803/0000899243-20-024803-index.htm
2019-03-29DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1771917/000095012319002954/0000950123-19-002954-index.htm
2019-05-02DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1771917/000095012319003798/0000950123-19-003798-index.htm
2019-05-02DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1771917/000095012319003800/0000950123-19-003800-index.htm
2019-05-22DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1771917/000095012319005650/0000950123-19-005650-index.htm
2019-05-22DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1771917/000095012319005651/0000950123-19-005651-index.htm
2019-10-28DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1771917/000095012319009749/0000950123-19-009749-index.htm
2019-07-12SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1771917/000107261319000230/0001072613-19-000230-index.htm
2019-12-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1771917/000107261319000314/0001072613-19-000314-index.htm
2019-11-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000110465919067183/0001104659-19-067183-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000110465920103494/0001104659-20-103494-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000110465920104277/0001104659-20-104277-index.htm
2019-07-03SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1771917/000114420419033738/0001144204-19-033738-index.htm
2019-05-31S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1771917/000119312519162773/0001193125-19-162773-index.htm
2019-06-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1771917/000119312519168148/0001193125-19-168148-index.htm
2019-06-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1771917/000119312519172947/0001193125-19-172947-index.htm
2019-06-17S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1771917/000119312519174168/0001193125-19-174168-index.htm
2019-06-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1771917/000119312519181182/0001193125-19-181182-index.htm
2019-06-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1771917/000119312519181184/0001193125-19-181184-index.htm
2019-06-268-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1771917/000119312519181807/0001193125-19-181807-index.htm
2019-06-27S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1771917/000119312519184370/0001193125-19-184370-index.htm
2019-06-28424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1771917/000119312519185971/0001193125-19-185971-index.htm
2019-07-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1771917/000119312519188306/0001193125-19-188306-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312519188361/0001193125-19-188361-index.htm
2019-07-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1771917/000119312519192457/0001193125-19-192457-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312519215963/0001193125-19-215963-index.htm
2019-08-0810-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1771917/000119312519216796/0001193125-19-216796-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312519286508/0001193125-19-286508-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312519293845/0001193125-19-293845-index.htm
2019-11-18S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1771917/000119312519294658/0001193125-19-294658-index.htm
2019-11-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1771917/000119312519294757/0001193125-19-294757-index.htm
2019-11-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1771917/000119312519294764/0001193125-19-294764-index.htm
2019-11-21424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1771917/000119312519297566/0001193125-19-297566-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312519297573/0001193125-19-297573-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312519304273/0001193125-19-304273-index.htm
2020-01-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1771917/000119312520012129/0001193125-20-012129-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520083104/0001193125-20-083104-index.htm
2020-03-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1771917/000119312520083794/0001193125-20-083794-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520121786/0001193125-20-121786-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1771917/000119312520126055/0001193125-20-126055-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1771917/000119312520126081/0001193125-20-126081-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520135496/0001193125-20-135496-index.htm
2020-05-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1771917/000119312520150747/0001193125-20-150747-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520171354/0001193125-20-171354-index.htm
2020-07-02S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1771917/000119312520186859/0001193125-20-186859-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520208124/0001193125-20-208124-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520209797/0001193125-20-209797-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520218261/0001193125-20-218261-index.htm
2020-08-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1771917/000119312520231433/0001193125-20-231433-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520265160/0001193125-20-265160-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520268619/0001193125-20-268619-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1771917/000119312520286130/0001193125-20-286130-index.htm
2019-06-26CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1771917/000135445719000335/0001354457-19-000335-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1771917/000156459019030379/0001564590-19-030379-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1771917/000156459019041326/0001564590-19-041326-index.htm
2020-03-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1771917/000156459020012311/0001564590-20-012311-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1771917/000156459020022328/0001564590-20-022328-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1771917/000156459020036400/0001564590-20-036400-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1771917/000156459020050820/0001564590-20-050820-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820000469/0001593968-20-000469-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820000621/0001593968-20-000621-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820000622/0001593968-20-000622-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820000623/0001593968-20-000623-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820000987/0001593968-20-000987-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820000988/0001593968-20-000988-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001055/0001593968-20-001055-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001099/0001593968-20-001099-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001100/0001593968-20-001100-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001152/0001593968-20-001152-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001316/0001593968-20-001316-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001317/0001593968-20-001317-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001420/0001593968-20-001420-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001421/0001593968-20-001421-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001422/0001593968-20-001422-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001423/0001593968-20-001423-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001424/0001593968-20-001424-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001425/0001593968-20-001425-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001465/0001593968-20-001465-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001466/0001593968-20-001466-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001492/0001593968-20-001492-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001546/0001593968-20-001546-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001570/0001593968-20-001570-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001630/0001593968-20-001630-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001631/0001593968-20-001631-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001750/0001593968-20-001750-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001751/0001593968-20-001751-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001752/0001593968-20-001752-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001858/0001593968-20-001858-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001859/0001593968-20-001859-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820001897/0001593968-20-001897-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820002023/0001593968-20-002023-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000159396820002123/0001593968-20-002123-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000172202419000015/0001722024-19-000015-index.htm
2019-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1771917/000172202419000017/0001722024-19-000017-index.htm
2019-06-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1771917/999999999519001462/9999999995-19-001462-index.htm
2019-11-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1771917/999999999519002626/9999999995-19-002626-index.htm
2019-05-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1771917/999999999719004260/9999999997-19-004260-index.htm
2019-06-25SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1771917/999999999719005779/9999999997-19-005779-index.htm

Karuna Therapeutics, Inc (KRTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Karuna Therapeutics, Inc (KRTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1453%
Institutional Ownership: 8742%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02Andrew Craig MillerChief Operating OfficerSell17,857.0086.611,546,594.770.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000621/0001593968-20-000621-index.htm
2020-04-01Andrew Craig MillerChief Operating OfficerSell10,654.0064.37685,797.980.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000988/0001593968-20-000988-index.htm
2020-05-01Andrew Craig MillerChief Operating OfficerSell25,000.0076.981,924,500.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001099/0001593968-20-001099-index.htm
2020-06-01Andrew Craig MillerChief Operating OfficerSell25,000.0090.642,266,000.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001316/0001593968-20-001316-index.htm
2020-06-12Atul PandeDirectorSell5,000.0093.27466,350.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001465/0001593968-20-001465-index.htm
2020-07-13Atul PandeDirectorSell5,000.0095.43477,150.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001631/0001593968-20-001631-index.htm
2020-08-12Atul PandeDirectorSell5,000.0085.00425,000.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001752/0001593968-20-001752-index.htm
2020-09-16Atul PandeDirectorSell5,000.0085.00425,000.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001897/0001593968-20-001897-index.htm
2020-11-03Atul PandeDirectorSell5,000.0085.00425,000.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820002123/0001593968-20-002123-index.htm
2020-03-02Troy A. IgnelziChief Financial OfficerSell7,500.0086.50648,750.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000623/0001593968-20-000623-index.htm
2020-05-08Troy A. IgnelziChief Financial OfficerSell7,500.0083.38625,350.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001152/0001593968-20-001152-index.htm
2020-06-15Troy A. IgnelziChief Financial OfficerSell4,000.0089.62358,480.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001492/0001593968-20-001492-index.htm
2020-06-15Troy A. IgnelziChief Financial OfficerSell2,000.0090.00180,000.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001492/0001593968-20-001492-index.htm
2020-06-16Troy A. IgnelziChief Financial OfficerSell2,000.00100.00200,000.000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001492/0001593968-20-001492-index.htm
2020-07-08Troy A. IgnelziChief Financial OfficerSell2,000.00100.00200,000.000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320018956/0000899243-20-018956-index.htm
2019-07-02BHARAT M CHOWRIRADirectorBuy5,000.0021.88109,399.5010,000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924319018913/0000899243-19-018913-index.htm
2020-05-01Stephen K. BrannanChief Medical OfficerBuy2,500.005.4513,625.0010,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001100/0001593968-20-001100-index.htm
2020-05-01Stephen K. BrannanChief Medical OfficerSell7,728.0079.38613,448.6410,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001100/0001593968-20-001100-index.htm
2019-06-28STEVEN M PAULPresident & CEOBuy3,200.0023.4374,976.0010,000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924319018747/0000899243-19-018747-index.htm
2019-07-02ARCH Venture Partners IX, LLC10% Share HolderBuy100,000.0016.001,600,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924319018905/0000899243-19-018905-index.htm
2020-02-19Stephen K. BrannanChief Medical OfficerBuy7,728.005.4542,117.6010,228.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000469/0001593968-20-000469-index.htm
2020-03-09EDMUND HARRIGANDirectorBuy105,163.00105,163.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320007992/0000899243-20-007992-index.htm
2020-06-29STEVEN M PAULPRESIDENT & CEOSell292,207.00103.5030,243,424.50106,485.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001546/0001593968-20-001546-index.htm
2020-04-01Andrew Craig MillerChief Operating OfficerBuy10,654.002.9231,109.6810,654.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000988/0001593968-20-000988-index.htm
2020-06-01Stephen K. BrannanChief Medical OfficerBuy2,500.005.4513,625.0012,500.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001317/0001593968-20-001317-index.htm
2020-06-01Stephen K. BrannanChief Medical OfficerSell7,728.0090.64700,465.9212,500.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001317/0001593968-20-001317-index.htm
2020-03-02Stephen K. BrannanChief Medical OfficerBuy7,728.007.2756,182.5612,728.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000622/0001593968-20-000622-index.htm
2020-04-01Andrew Craig MillerChief Operating OfficerBuy14,346.007.27104,295.4214,346.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000988/0001593968-20-000988-index.htm
2020-07-01Stephen K. BrannanChief Medical OfficerBuy2,500.005.4513,625.0015,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001570/0001593968-20-001570-index.htm
2020-07-01Stephen K. BrannanChief Medical OfficerSell7,728.00108.53838,719.8415,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001570/0001593968-20-001570-index.htm
2020-04-01Stephen K. BrannanChief Medical OfficerBuy7,728.009.2071,097.6015,228.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000987/0001593968-20-000987-index.htm
2020-01-03Heather PrestonDirectorBuy1,138.0070.0079,660.001,612.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320000737/0000899243-20-000737-index.htm
2019-07-02ROBERT NELSENDirectorBuy100,000.0016.001,600,000.001,681,435.00https://www.sec.gov/Archives/edgar/data/1771917/000089924319018910/0000899243-19-018910-index.htm
2019-07-02ROBERT NELSENDirectorBuy100,000.0016.001,600,000.001,681,437.00https://www.sec.gov/Archives/edgar/data/1771917/000089924319018910/0000899243-19-018910-index.htm
2019-07-02JAMES HEALYDirectorBuy700,000.0016.0011,200,000.001,729,352.00https://www.sec.gov/Archives/edgar/data/1771917/000089924319018907/0000899243-19-018907-index.htm
2020-05-01Stephen K. BrannanChief Medical OfficerBuy7,728.005.4542,117.6017,728.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001100/0001593968-20-001100-index.htm
2020-03-02Andrew Craig MillerChief Operating OfficerBuy17,857.002.9252,142.4417,857.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000621/0001593968-20-000621-index.htm
2019-12-31Heather PrestonDirectorBuy185.0070.0012,950.00185.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320000296/0000899243-20-000296-index.htm
2019-11-25JAMES HEALYDirectorBuy156,250.0096.0015,000,000.001,885,602.00https://www.sec.gov/Archives/edgar/data/1771917/000110465919067183/0001104659-19-067183-index.htm
2020-09-04JAMES HEALYDirectorBuy1,670.0070.12117,100.401,887,272.00https://www.sec.gov/Archives/edgar/data/1771917/000110465920103494/0001104659-20-103494-index.htm
2020-09-04JAMES HEALYDirectorBuy45,317.0071.303,231,102.101,932,589.00https://www.sec.gov/Archives/edgar/data/1771917/000110465920103494/0001104659-20-103494-index.htm
2020-09-04JAMES HEALYDirectorBuy6,461.0072.73469,908.531,939,050.00https://www.sec.gov/Archives/edgar/data/1771917/000110465920103494/0001104659-20-103494-index.htm
2020-09-04JAMES HEALYDirectorBuy8,330.0073.59613,004.701,947,380.00https://www.sec.gov/Archives/edgar/data/1771917/000110465920103494/0001104659-20-103494-index.htm
2020-09-08JAMES HEALYDirectorBuy504.0073.0036,792.001,947,884.00https://www.sec.gov/Archives/edgar/data/1771917/000110465920103494/0001104659-20-103494-index.htm
2020-09-09JAMES HEALYDirectorBuy4,557.0073.75336,078.751,952,441.00https://www.sec.gov/Archives/edgar/data/1771917/000110465920104277/0001104659-20-104277-index.htm
2020-06-15Troy A. IgnelziChief Financial OfficerBuy2,000.009.2018,400.002,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001492/0001593968-20-001492-index.htm
2020-06-16Troy A. IgnelziChief Financial OfficerBuy2,000.009.2018,400.002,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001492/0001593968-20-001492-index.htm
2020-07-08Troy A. IgnelziChief Financial OfficerSell6,000.0098.32589,920.002,000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320018956/0000899243-20-018956-index.htm
2020-06-01Stephen K. BrannanChief Medical OfficerBuy7,728.007.2756,182.5620,228.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001317/0001593968-20-001317-index.htm
2020-07-01Stephen K. BrannanChief Medical OfficerBuy7,728.009.2071,097.6022,728.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001570/0001593968-20-001570-index.htm
2020-01-09Heather PrestonDirectorBuy788.0070.5055,554.002,400.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320000978/0000899243-20-000978-index.htm
2019-07-02Alexandria Venture Investments, LLC10% Share HolderBuy30,000.0016.00480,000.00244,447.00https://www.sec.gov/Archives/edgar/data/1771917/000172202419000017/0001722024-19-000017-index.htm
2020-02-19Stephen K. BrannanChief Medical OfficerBuy2,500.005.4513,625.002,500.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000469/0001593968-20-000469-index.htm
2020-02-19Stephen K. BrannanChief Medical OfficerSell7,728.00101.63785,396.642,500.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000469/0001593968-20-000469-index.htm
2020-05-01Andrew Craig MillerChief Operating OfficerBuy25,000.007.27181,750.0025,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001099/0001593968-20-001099-index.htm
2020-06-01Andrew Craig MillerChief Operating OfficerBuy25,000.007.27181,750.0025,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001316/0001593968-20-001316-index.htm
2020-06-15Andrew Craig MillerChief Operating OfficerBuy33,000.002.9296,360.0033,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-06-12Andrew Craig MillerChief Operating OfficerSell4,968.0093.28463,415.0433,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-06-15Andrew Craig MillerChief Operating OfficerSell3,571.0092.38329,888.9833,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-06-16Andrew Craig MillerChief Operating OfficerSell8,334.0097.58813,231.7233,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-09-10Andrew Craig MillerChief Operating OfficerSell5,000.0075.52377,600.0033,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001859/0001593968-20-001859-index.htm
2020-10-12Andrew Craig MillerChief Operating OfficerSell5,000.0078.67393,350.0033,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820002023/0001593968-20-002023-index.htm
2020-03-10Heather PrestonDirectorBuy1,000.0080.0080,000.003,400.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320008109/0000899243-20-008109-index.htm
2020-08-26PureTech Health LLC10% Share HolderSell1,333,333.0076.21101,616,241.263,406,564.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320023459/0000899243-20-023459-index.htm
2020-06-12Andrew Craig MillerChief Operating OfficerBuy3,365.009.2030,958.0036,365.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-06-15Andrew Craig MillerChief Operating OfficerBuy3,571.007.2725,961.1736,571.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-06-15Andrew Craig MillerChief Operating OfficerBuy4,762.009.2043,810.4037,762.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-06-12Andrew Craig MillerChief Operating OfficerBuy4,968.007.2736,117.3637,968.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-09-10Andrew Craig MillerChief Operating OfficerBuy5,000.007.2736,350.0038,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001859/0001593968-20-001859-index.htm
2020-10-12Andrew Craig MillerChief Operating OfficerBuy5,000.007.2736,350.0038,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820002023/0001593968-20-002023-index.htm
2020-03-12Heather PrestonDirectorBuy550.0069.1738,042.793,950.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320008109/0000899243-20-008109-index.htm
2020-06-29STEVEN M PAULPRESIDENT & CEOBuy292,207.000.1132,142.77398,692.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001546/0001593968-20-001546-index.htm
2020-06-15Troy A. IgnelziChief Financial OfficerBuy4,000.009.2036,800.004,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001492/0001593968-20-001492-index.htm
2020-06-16Andrew Craig MillerChief Operating OfficerBuy8,334.009.2076,672.8041,334.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001477/0001593968-20-001477-index.htm
2020-03-12Heather PrestonDirectorBuy500.0070.0035,000.004,450.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320008109/0000899243-20-008109-index.htm
2020-05-22PureTech Health LLC10% Share HolderSell5,500.0084.50464,750.004,739,897.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320014094/0000899243-20-014094-index.htm
2020-01-03Heather PrestonDirectorBuy289.0069.0019,941.00474.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320000737/0000899243-20-000737-index.htm
2020-05-22PureTech Health LLC10% Share HolderSell550,000.0081.0044,550,000.004,745,397.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320014094/0000899243-20-014094-index.htm
2020-03-12Heather PrestonDirectorBuy500.0073.0036,500.004,950.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320008109/0000899243-20-008109-index.htm
2020-06-12Atul PandeDirectorBuy5,000.002.9214,600.005,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001465/0001593968-20-001465-index.htm
2020-07-13Atul PandeDirectorBuy5,000.002.9214,600.005,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001631/0001593968-20-001631-index.htm
2020-08-12Atul PandeDirectorBuy5,000.002.9214,600.005,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001752/0001593968-20-001752-index.htm
2020-09-16Atul PandeDirectorBuy5,000.002.9214,600.005,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001897/0001593968-20-001897-index.htm
2020-11-03Atul PandeDirectorBuy5,000.002.9214,600.005,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820002123/0001593968-20-002123-index.htm
2019-07-01BHARAT M CHOWRIRADirectorBuy5,000.0020.55102,740.505,000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924319018913/0000899243-19-018913-index.htm
2020-03-02Stephen K. BrannanChief Medical OfficerBuy2,500.005.4513,625.005,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000622/0001593968-20-000622-index.htm
2020-03-02Stephen K. BrannanChief Medical OfficerSell7,728.0086.55668,858.405,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000622/0001593968-20-000622-index.htm
2020-08-25Troy A. IgnelziChief Financial OfficerBuy5,000.009.2046,000.005,000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320023521/0000899243-20-023521-index.htm
2020-09-08Troy A. IgnelziChief Financial OfficerSell2,000.0073.30146,600.005,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001858/0001593968-20-001858-index.htm
2020-01-22PureTech Health LLC10% Share HolderSell2,100,000.0095.67200,907,000.005,295,397.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320001979/0000899243-20-001979-index.htm
2020-03-12Heather PrestonDirectorBuy500.0074.9137,455.005,450.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320008109/0000899243-20-008109-index.htm
2020-08-12EDMUND HARRIGANDirectorSell10,000.0083.32833,200.0055,163.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001750/0001593968-20-001750-index.htm
2020-09-04Heather PrestonDirectorBuy350.0072.3625,326.005,800.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320024803/0000899243-20-024803-index.htm
2020-07-08Troy A. IgnelziChief Financial OfficerBuy6,000.009.2055,200.006,000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320018956/0000899243-20-018956-index.htm
2020-07-13EDMUND HARRIGANDirectorSell10,000.0093.40934,000.0065,163.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001630/0001593968-20-001630-index.htm
2019-06-28STEVEN M PAULPresident & CEOBuy6,800.0022.86155,448.006,800.00https://www.sec.gov/Archives/edgar/data/1771917/000089924319018747/0000899243-19-018747-index.htm
2020-09-08Troy A. IgnelziChief Financial OfficerBuy2,000.009.2018,400.007,000.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001858/0001593968-20-001858-index.htm
2020-03-02Andrew Craig MillerChief Operating OfficerBuy7,143.002.9220,857.567,143.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000621/0001593968-20-000621-index.htm
2020-04-01Stephen K. BrannanChief Medical OfficerBuy2,500.005.4513,625.007,500.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000987/0001593968-20-000987-index.htm
2020-04-01Stephen K. BrannanChief Medical OfficerSell7,728.0067.36520,558.087,500.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000987/0001593968-20-000987-index.htm
2020-03-02Troy A. IgnelziChief Financial OfficerBuy7,500.009.2069,000.007,500.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820000623/0001593968-20-000623-index.htm
2020-05-08Troy A. IgnelziChief Financial OfficerBuy7,500.009.2069,000.007,500.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001152/0001593968-20-001152-index.htm
2020-06-12EDMUND HARRIGANDirectorSell30,000.0091.792,753,700.0075,163.00https://www.sec.gov/Archives/edgar/data/1771917/000159396820001466/0001593968-20-001466-index.htm
2020-07-08Troy A. IgnelziChief Financial OfficerBuy2,000.009.2018,400.008,000.00https://www.sec.gov/Archives/edgar/data/1771917/000089924320018956/0000899243-20-018956-index.htm